首页 >
法规速递
-
Guidance for Industry: Protein Efficiency Ratio (PER) Rat Bioassay Studies to Demonstrate that a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein-2026/5/21
2026-05-22查看详情 > -
国家药监局药审中心关于发布《中药新药用于慢性胃炎的临床疗效评价技术指导原则（试行）》《中药新药用于胃食管反流病的临床疗效评价技术指导原则（试行）》的通告（2022年第47号）-2022/12/21
2022-12-22查看详情 > -
国家药监局综合司公开征求《药品检查管理办法（试行）》部分条款修订意见-2023/6/30
2023-06-30查看详情 > -
Draft Guidance: Quality Considerations for Topical Ophthalmic Drug Products-2023/12/27
2024-01-03查看详情 > -
Document: Minutes of the CVMP meeting 3-5 December 2024-2025/1/24
2025-02-05查看详情 > -
Document: Infographic - Orphan Medicines in the EU-2025/2/27
2025-03-03查看详情 > -
国家药监局关于进一步做好《药品生产许可证》发放有关事项的公告（2025年第35号）-2025/4/7
2025-04-08查看详情 > -
Document: Annex - National provisions for SMEs applicable to the pharmaceutical sector-2025/5/15
2025-05-16查看详情 > -
六部门联合发布《关于将4-哌啶酮和1-叔丁氧羰基-4-哌啶酮列为易制毒化学品管理的公告》-2025/6/25
2025-06-26查看详情 > -
Document: Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion-2025/7/28
2025-07-29查看详情 >
